0001104659-20-134929.txt : 20201211
0001104659-20-134929.hdr.sgml : 20201211
20201211205909
ACCESSION NUMBER: 0001104659-20-134929
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUYER DAVID R
CENTRAL INDEX KEY: 0001277476
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 201384894
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
tm2038354-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2020-12-09
0
0001410939
IVERIC bio, Inc.
ISEE
0001277476
GUYER DAVID R
C/O IVERIC BIO, INC.
ONE PENN PLAZA, 35TH FLOOR
NEW YORK
NY
10119
1
1
0
0
Executive Chairman
Common Stock
2020-12-09
4
M
0
17813
A
71785
D
Common Stock
2020-12-10
4
S
0
9602
6.96
D
62183
D
Restricted Stock Units
2020-12-09
4
A
0
17813
0
D
Common Stock
17813
53437
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 9, 2020.
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $6.83 to $7.05 on December 10, 2020 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
On December 9, 2019, the Reporting Person was granted an award of 71,250 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.
/s/ Todd Anderman, as Attorney-in-Fact for David R. Guyer
2020-12-11